Search Clinical Trials
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Select a Condition or Specialty
- Allergy
- Alpha-1 Antitrypsin Deficiency
- Asthma
- Cardiology
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19 (Coronavirus)
- Cystic Fibrosis
- Eczema (Atopic Dermatitis)
- Environmental & Occupational Health
- Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- Food Allergy
- Gastroenterology
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (Pulmonary Fibrosis)
- Lung Cancer
- Oncology
- Pulmonary Hypertension (PH)
- Respiratory (Pulmonary)
- Rheumatology
- Sarcoidosis
All Clinical Trials
Potential Treatment for Dry Skin in Pediatric Eczema Patients
In severe asthma, some of the exacerbations that cause difficulty breathing are the result of inflammation in the lung. Researchers are testing a class of anti-inflammatory drugs called a JAK1 inhibitor that has worked to treat other inflammatory conditions like eczema to see if it can help people with severe asthma.
- Gender
- Any
- Ages
- 6-12
- Compensation
- Provided
- Time Required
- Approximately 11 clinic visits spread into three periods (screening, intervention, and follow-up) over the course of two years.
SEAL Study: Stopping Eczema and Allergy
Can allergies be prevented in infants? Researchers want to know if keeping a baby’s skin healthy and hydrated with moisturizer will prevent the child from developing allergies such as food allergies. Learn how you and your child can help researchers.
- Gender
- Any
- Ages
- Newborn to 12-weeks-old
- Compensation
- Provided
- Time Required
- Three years, with six clinic visits and weekly or monthly phone calls with researchers
Skin, Airway & Esophageal Epithelial Barriers in Youth
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
- Gender
- Any
- Ages
- 2-21
- Compensation
- Provided
- Time Required
- Not Specified
SUNBEAM: Studying Allergy Development in Babies
Why do babies develop food allergies and eczema? Researchers are studying factors before birth and through age 3 that may influence the development of allergic conditions.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Up to 3 years of participation
Atopic Dermatitis & Skin Infections
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
- Gender
- Any
- Ages
- 18-65
- Compensation
- Provided
- Time Required
- Up to 3 visits or approximately 3 hours
Understanding Skin Problems from Eczema and Food Allergies
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
- Gender
- Any
- Ages
- Not Specified
- Compensation
- Provided
- Time Required
- Not Specified
ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
Eczema (atopic dermatitis) is typically classified as mild, moderate or severe. In this trial, researchers are studying gene expression for the varying severity levels of eczema in order to guide new and improved treatments strategies and more personalized treatments.
- Gender
- Any
- Ages
- 6-65
- Compensation
- Provided
- Time Required
- 7-8 clinic visits over five to six months.
Adult Trials
Skin, Airway & Esophageal Epithelial Barriers in Youth
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
- Gender
- Any
- Ages
- 2-21
- Compensation
- Provided
- Time Required
- Not Specified
SUNBEAM: Studying Allergy Development in Babies
Why do babies develop food allergies and eczema? Researchers are studying factors before birth and through age 3 that may influence the development of allergic conditions.
- Gender
- Any
- Ages
- 18+
- Compensation
- Provided
- Time Required
- Up to 3 years of participation
Atopic Dermatitis & Skin Infections
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
- Gender
- Any
- Ages
- 18-65
- Compensation
- Provided
- Time Required
- Up to 3 visits or approximately 3 hours
Understanding Skin Problems from Eczema and Food Allergies
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
- Gender
- Any
- Ages
- Not Specified
- Compensation
- Provided
- Time Required
- Not Specified
ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
Eczema (atopic dermatitis) is typically classified as mild, moderate or severe. In this trial, researchers are studying gene expression for the varying severity levels of eczema in order to guide new and improved treatments strategies and more personalized treatments.
- Gender
- Any
- Ages
- 6-65
- Compensation
- Provided
- Time Required
- 7-8 clinic visits over five to six months.
Pediatric Trials
Potential Treatment for Dry Skin in Pediatric Eczema Patients
In severe asthma, some of the exacerbations that cause difficulty breathing are the result of inflammation in the lung. Researchers are testing a class of anti-inflammatory drugs called a JAK1 inhibitor that has worked to treat other inflammatory conditions like eczema to see if it can help people with severe asthma.
- Gender
- Any
- Ages
- 6-12
- Compensation
- Provided
- Time Required
- Approximately 11 clinic visits spread into three periods (screening, intervention, and follow-up) over the course of two years.
SEAL Study: Stopping Eczema and Allergy
Can allergies be prevented in infants? Researchers want to know if keeping a baby’s skin healthy and hydrated with moisturizer will prevent the child from developing allergies such as food allergies. Learn how you and your child can help researchers.
- Gender
- Any
- Ages
- Newborn to 12-weeks-old
- Compensation
- Provided
- Time Required
- Three years, with six clinic visits and weekly or monthly phone calls with researchers
Skin, Airway & Esophageal Epithelial Barriers in Youth
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
- Gender
- Any
- Ages
- 2-21
- Compensation
- Provided
- Time Required
- Not Specified
Understanding Skin Problems from Eczema and Food Allergies
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
- Gender
- Any
- Ages
- Not Specified
- Compensation
- Provided
- Time Required
- Not Specified
ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
Eczema (atopic dermatitis) is typically classified as mild, moderate or severe. In this trial, researchers are studying gene expression for the varying severity levels of eczema in order to guide new and improved treatments strategies and more personalized treatments.
- Gender
- Any
- Ages
- 6-65
- Compensation
- Provided
- Time Required
- 7-8 clinic visits over five to six months.
Healthy Participant Trials
Atopic Dermatitis & Skin Infections
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
- Gender
- Any
- Ages
- 18-65
- Compensation
- Provided
- Time Required
- Up to 3 visits or approximately 3 hours
Understanding Skin Problems from Eczema and Food Allergies
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
- Gender
- Any
- Ages
- Not Specified
- Compensation
- Provided
- Time Required
- Not Specified
ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
Eczema (atopic dermatitis) is typically classified as mild, moderate or severe. In this trial, researchers are studying gene expression for the varying severity levels of eczema in order to guide new and improved treatments strategies and more personalized treatments.
- Gender
- Any
- Ages
- 6-65
- Compensation
- Provided
- Time Required
- 7-8 clinic visits over five to six months.